Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings

The summary for the Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings: The purpose of this notice of funding opportunity is to support research on Long-Acting Injectable-Antiretroviral Therapy (LAI-ART) by implementing LAI-ART administration in both clinic and non-clinic settings (e.g., community pharmacies). A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART. Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability. Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression. The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.

Federal Grant Title:	Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-23-004
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 27th, 2023
Original Application Deadline:	February 27th, 2023
Posted Date:	December 22nd, 2022
Creation Date:	December 22nd, 2022
Archive Date:	March 29th, 2023
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:	$1,000,000
Minimum Federal Grant Award:	$750,000
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	December 23rd, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses
Additional Information on Eligibility: N/A
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
[email protected]
Similar Government Grants: • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...; • Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...; • Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...; • PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...